Pacific Biosciences is trading at $1.96, up 6.36%, with the Verily Health collaboration the clearest company-specific catalyst in available reporting. - The multi-year collaboration connects HiFi sequencing with Verily’s data and AI platform to create AI-ready genomic and clinical datasets; financial terms were not disclosed. - A separate report said shares rose after the announcement on October 19. - No distinct October 20 company announcement or reliable volume information was identified; supplied price context reports the live move.